HF, Confirmatory Phase 3 Clinical Trial of Omecamtiv Mecarbil, and AMBER-HFpEF, Phase 2 Clinical Trial of CK-586, Expected to ...
In a report released today, Carter Gould from Barclays maintained a Buy rating on Cytokinetics (CYTK – Research Report), with a price ...
Jason Butler, an analyst from JMP Securities, reiterated the Buy rating on Cytokinetics (CYTK – Research Report). The associated price ...
Purpose-driven marketing elevates brand-consumer relationships beyond transactional interactions. By linking brand values ...
The biological needs of plants and animals affect their cells' protein content, but the story goes deeper than that.
Live imaging at single-vesicle resolution reveals rabphilin-3A as the first identified negative regulator of neuropeptide release in mammalian neurons.
ORDINARY aqueous or potassium chloride extracts of muscle exhibit but a slight capacity to mineralize adenosinetriphosphate. Even this slight liberation of phosphate is mainly due, not to direct ...